Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes
LEHI, Utah, Oct. 23, 2025 /PRNewswire/ --Â Halia Therapeutics, Inc., a clinical-stage biopharmaceutical…
realbuzz Raise over 12.6M Globally For Charity
Friday 4 July, 2025 Manchester-based global fundraising platform realbuzz has revealed a…
